In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Study groups

Ischemic Heart Disease and Acute Cardiac Care

ACCA has created five expert study groups aimed at advancing the science in the fields and the writing of consensus, position, guidelines papers in order to increase ACCA leadership position in those fields.

Each group is under the supervision of the ACCA scientific committee but has the entire freedom to recruit experts, propose and run its activities.

  • Biomarkers – Focusing on the proper clinical application of cardiac biomarkers.
    Created in the years 2000 and led by Kristian Thygesen (DE), the biomarker group is now an important component of ACCA. The structure and strategic plan of the group was revised at the ESC Congress 2012.
    It is now chaired by Bertil Lindhal (SW).
  • Acute Heart Failure - Highlighting unmet needs and areas of uncertainty in the care of acute HF patients.
    Created in May 2013, this group is under the leadership of Christian Mueller (CH).
  • Pre-hospital care – Promoting studies, registries and educational initiatives in the management of sudden cardiac death and acute coronary syndromes.
    Initiated by Eva Swhan (SW) in 2008, it is re-appearing on the scene of ACCA in 2013, led by Farzin Beygui (FR).
  • Quality Of Care (QoC) - composed of experts focusing on QoC within acute cardiac care situations. The study group is interdisciplinary and international, under the leadership of Prof. Francois Schiele.

  • Spontaneous Coronary Artery Dissection (SCAD) - It aims to improve awareness and understanding of this rare coronary artery disease. This group has been created in January 2016 under the leadership of Dr David Adlam (UK) and Prof Christiaan Vrints (BE)